OrthoPediatrics Corp. (NASDAQ:KIDS) Given Average Rating of “Moderate Buy” by Brokerages

Shares of OrthoPediatrics Corp. (NASDAQ:KIDS) have been given a consensus recommendation of “Moderate Buy” by the eleven brokerages that are currently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, one has assigned a hold recommendation, eight have given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $23.8889.

Several research analysts recently issued reports on the company. JMP Securities reduced their target price on OrthoPediatrics from $35.00 to $25.00 and set a “market outperform” rating on the stock in a research report on Friday, October 10th. TD Cowen upgraded OrthoPediatrics to a “strong-buy” rating in a research note on Tuesday, January 27th. BTIG Research reaffirmed a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a research report on Wednesday, October 29th. Lake Street Capital dropped their target price on shares of OrthoPediatrics from $37.00 to $34.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Stifel Nicolaus cut their price target on shares of OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating on the stock in a research note on Friday, October 10th.

OrthoPediatrics Trading Up 0.4%

Shares of NASDAQ KIDS opened at $16.65 on Friday. OrthoPediatrics has a twelve month low of $15.28 and a twelve month high of $26.40. The business has a fifty day simple moving average of $17.91 and a two-hundred day simple moving average of $18.56. The firm has a market cap of $417.58 million, a PE ratio of -8.54 and a beta of 1.12. The company has a quick ratio of 3.52, a current ratio of 7.40 and a debt-to-equity ratio of 0.28.

Institutional Trading of OrthoPediatrics

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. Russell Investments Group Ltd. grew its stake in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock valued at $26,000 after purchasing an additional 1,139 shares during the last quarter. Caption Management LLC purchased a new stake in OrthoPediatrics in the third quarter valued at approximately $54,000. BNP Paribas Financial Markets increased its holdings in OrthoPediatrics by 60.2% in the 3rd quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the period. FourThought Financial Partners LLC purchased a new position in OrthoPediatrics during the 4th quarter worth approximately $197,000. Finally, Los Angeles Capital Management LLC acquired a new stake in OrthoPediatrics during the 2nd quarter valued at approximately $220,000. Institutional investors and hedge funds own 69.05% of the company’s stock.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.